IFPMA - 28th eBIC Committee meeting

On May 12,13,14, the IFPMA Ethics Group held a series of virtual conferences for members related to the pandemic situation. The session was attended by about 70 IFPMA member companies and associations.

The session was attended by 70 IFPMA member companies and associations. The session was opened by Mr. Rady Johnson, Chair of the IFPMA Ethics and Business Integrity Committee and Pfizer’ Chief Compliance, Quality and Risk Officer. He noted that, as we wage to fight Covid 19, business continuity plans are being tested as never before. Heroic collegues work tirelessly in plants to ensure the supply of medicines patients already depend on. They continue to provide healthcare professionals with critical information they need to treat their patients and the scientists and researchers around the globe work urgently to develop and test the diagnostics, treatments and vaccines that this global crisis demands. While operating in this uncharted territories it must demonstrated to the world that it can count on innovation, commitment, courage, resilience and above all, integrity to win this fight. As we continue what looks to be a long ride the need of the ethos has never been more clear. With the core value of trust, care, fareness, respect and honesty the ethos provides the framework to ensure that, especially in the face of a crisis, we act with integrity. With the ethos front-and-center, the integrity of the decisions and actions are made while navigating this crisis is assured. And more iportantly, long after the crisis has ended, society will see and aplaude this integrity.

 Presentations were made by three working groups:

  • Patient Centricity WG;
  • Code Capacity Building WG;
  • International Government Organisations WG.

On the third day was discussed:

  • CV19 and Bioethics;
  • Bioethics of Data Sharing and Secondary Use;
  • Functioning of pharmaceutical companies in a virtual mode.

Association of Pharmacetical Companies Representatives donation for StopCov Fund

Today, on April 29th , donation in amount of 35,000 GEL was transferred by our Association, to STOPCOV fund (State Treasury Fund) created by the Government of Georgia to fight COVID 19.


Funding a charity dinner

Association of Pharmaceutical Companies Representatives in Georgia, like in previous years, funded a 3-day free dinner at the House of Charity - "Catharsis" for Easter, during which more than 1,000 people will receive a free dinner.


New member of APCRG - Egis Pharmaceuticals PLC representation in Georgia

APCRG members general meeting has accepted and validated membership request, submitted by the Georgian representation of the company Egis Pharmaceuticals PLC. More information about the company and it's international operations can be seen on company website.


The 11th EAEU and CIS pharmaceutical forum

The 11th EAEU and CIS pharmaceutical forum, organized by Adam Smith was held in Moscow, on February 26-28th.

The forum discussed the burning issues facing the pharmaceutical sector today as well as future forecasts and opportunities. The event was attended by the chairman of APCRG, Grigori Pirtskhalaishvili, who introduced the presentation, prepared by him.

Photomaterials can be found on the link.


Georgia-EU Investment Council meeting

Georgia-EU Investment Council meeting on Pharmacy (Main topic: Problems with implementation of GMP standards) was held at Hotel Rooms. The meeting was attended by, Mr. Irakli Margvelashvili, Executive Director of APCRG.


Tbilisi-Cancer Challenge City

In connection with the world Cancer day, the presentation of the outcomes of one-year work and future plans set within the initiative “Tbilisi-Cancer Challenge City” was conducted.

The event was opened by Deputy Minister of Internally Displaced Persons from the Occupied Territories, Labor, Health and Social Affairs of Georgia, Zaza Bokhua. The event was attended by Director of APCRG Mr. Irakli Margvelashvili. 


Meeting organized by the Competition Agency

Within the framework of the monitoring of the pharmaceutical market by the Competition Agency, consultations / workshops were held with experts in the pharmaceutical field and relevant associations. The meeting was attended by APCRG Director - Mr. Irakli Margvelashvili.


Closing event of the EU-funded Project “Support to the Georgian Competition Agency”

Closing event of the EU-funded Project “Support to the Georgian Competition Agency” was held on January 10th. The event was attended by Director of APCRG Mr. Irakli Margvelashvili, head of the Board Grigori Phirtskhalaishvili and Head of Servier Representative Office Maia Khetsuriani.


Updated Code of Ethics

In 2019 the Code of Ethics of the Association of Pharmaceutical Companies has been updated in accordance with the requirements of the Code of Ethics developed by IFPMA, the version of which can be found here.